Newmont
Official SEC filings
Source: SEC EDGAR. Latest available cached filings; filing date is not the financial period end. Index checked: 2026-11-22 10:43 UTC.
| Form | Filed | Original document |
|---|---|---|
| 10-Q | 2026-10-22 | Read on SEC.gov |
| 8-K | 2026-10-22 | Read on SEC.gov |
| 8-K | 2026-08-20 | Read on SEC.gov |
| 8-K | 2026-08-13 | Read on SEC.gov |
| 10-Q | 2026-07-23 | Read on SEC.gov |
| 8-K | 2026-07-23 | Read on SEC.gov |
| 8-K | 2026-06-15 | Read on SEC.gov |
| 8-K | 2026-05-13 | Read on SEC.gov |
SEC annual financial snapshot
Standard US-GAAP facts in 10-K filings, USD. Income and cash flow cover the annual period; balance-sheet amounts are as of period end. These are not quarterly or TTM figures. Latest available filed values may include restatements; reporting periods can differ from other providers. Checked: 2026-11-22 12:51 UTC.
| Metric | USD | Basis | Period end | Filed | Source |
|---|---|---|---|---|---|
| Revenue | $22.67B | Annual | 2025-12-31 | 2026-02-19 | 10-K |
| Net income | $7.09B | Annual | 2025-12-31 | 2026-02-19 | 10-K |
| Operating cash flow | $10.33B | Annual | 2025-12-31 | 2026-02-19 | 10-K |
| Total assets | $57.12B | As of | 2025-12-31 | 2026-02-19 | 10-K |
| Total liabilities | $23.08B | As of | 2025-12-31 | 2026-02-19 | 10-K |
| Stockholders’ equity | $33.87B | As of | 2025-12-31 | 2026-02-19 | 10-K |
| Cash and cash equivalents | $7.65B | As of | 2025-12-31 | 2026-02-19 | 10-K |
✦ Quant Financial Health how this is computed
- Altman Z-Score is 3.83, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
✦ Quant Revenue Concentration how this is computed
- Nevada Gold Mines (NGM) is the largest reported line at 16.60% of revenue, across 10 reported segments.
- No single line clears half of revenue; Penasquito is next at 16.36%, spreading the business across more than one real driver.
Revenue annual, last 8 years
Latest year +21.34% YoY
Margins
- Gross margin
- 53.21%
- Operating margin
- 48.63%
- Net margin
- 31.25%
Key ratios & quality
- Enterprise valuei
- 95.38B
- Altman Z-Scorei
- 3.83
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.25B | 9.74B | 11.50B | 12.22B | 11.92B | 11.81B | 18.68B | 22.67B |
| Gross profit | 1.95B | 2.59B | 4.18B | 4.46B | 3.26B | 3.01B | 7.14B | 12.06B |
| Selling & admin expenses | 244.00M | 313.00M | 269.00M | 259.00M | 276.00M | 299.00M | 442.00M | 382.00M |
| Research & development | 153.00M | 150.00M | 122.00M | 154.00M | 229.00M | 200.00M | 197.00M | 166.00M |
| Operating profit | 1.19B | 1.58B | 3.06B | 2.00B | 1.61B | 708.00M | 5.91B | 11.02B |
| Pretax profit | 738.00M | 3.69B | 3.14B | 1.11B | -51.00M | -2.03B | 4.58B | 11.34B |
| Tax | 386.00M | 832.00M | 704.00M | 1.10B | 455.00M | 526.00M | 1.40B | 4.60B |
| Net profit | 380.00M | 2.88B | 2.79B | 233.00M | -369.00M | -2.47B | 3.38B | 7.17B |
| Basic EPS | 1 | 4 | 4 | 1 | -1 | -3 | 3 | 6 |
| Diluted EPS | 0.64 | 3.81 | 3.51 | 1.46 | -0.54 | -2.97 | 2.92 | 6.39 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Revenue | 5.32B | 5.52B | 6.82B | 7.31B | 6.12B | 6.36B |
| Gross profit | 2.70B | 2.93B | 4.13B | 4.74B | 3.43B | 3.59B |
| Selling & admin expenses | 95.00M | 86.00M | 91.00M | 79.00M | 74.00M | 82.00M |
| Research & development | 40.00M | 40.00M | 43.00M | 45.00M | 47.00M | 58.00M |
| Operating profit | 2.42B | 2.62B | 3.97B | 4.49B | 3.16B | 3.18B |
| Pretax profit | 3.12B | 2.51B | 3.25B | 4.58B | 3.00B | 3.21B |
| Tax | 1.09B | 787.00M | 2.07B | 1.40B | 952.00M | 839.00M |
| Net profit | 2.08B | 1.84B | 1.35B | 3.33B | 2.25B | 2.51B |
| Basic EPS | 2 | 2 | 1 | 3 | 2 | 2 |
| Diluted EPS | 1.85 | 1.67 | 1.19 | 3.00 | 2.06 | 2.35 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 5.28B | 6.27B | 8.51B | 7.70B | 6.52B | 7.51B | 12.28B | 13.07B |
| Cash & ST investments | 3.45B | 2.48B | 5.83B | 5.07B | 3.76B | 3.03B | 3.64B | 8.24B |
| Inventory | 1.33B | 1.83B | 1.79B | 1.79B | 1.75B | 2.64B | 2.18B | 2.69B |
| Total assets | 20.72B | 39.97B | 41.37B | 40.56B | 38.48B | 55.51B | 56.35B | 57.12B |
| Total current liabilities | 1.79B | 2.39B | 3.37B | 2.65B | 2.93B | 6.00B | 7.54B | 5.71B |
| Short-term debt | 653.00M | 128.00M | 657.00M | 193.00M | 96.00M | 2.04B | 1.03B | 118.00M |
| Long-term debt | 3.42B | 6.14B | 5.48B | 5.57B | 5.57B | 6.95B | 7.55B | 5.12B |
| Total liabilities | 9,203,000,000.00 | 17,557,000,000.00 | 17,490,000,000.00 | 18,703,000,000.00 | 18,949,000,000.00 | 26,301,000,000.00 | 26,240,000,000.00 | 23,079,000,000.00 |
| Total equity | 11.51B | 22.42B | 23.88B | 21.86B | 19.53B | 29.21B | 30.11B | 34.04B |
| Retained earnings | 383.00M | 2.29B | 4.00B | 3.10B | 916.00M | -3.00B | -1.32B | 3.43B |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Total current assets | 10.40B | 10.37B | 13.07B | 13.51B | 13.31B | 13.57B |
| Cash & ST investments | 6.65B | 5.97B | 8.24B | 8.78B | 9.01B | 8.83B |
| Inventory | 2.27B | 2.45B | 2.69B | 2.71B | 2.80B | 2.90B |
| Total assets | 55.17B | 54.69B | 57.12B | 57.67B | 57.64B | 58.18B |
| Total current liabilities | 4.67B | 5.09B | 5.71B | 5.53B | 5.23B | 5.54B |
| Short-term debt | 112.00M | 116.00M | 118.00M | 116.00M | 132.00M | 134.00M |
| Long-term debt | 7.13B | 5.18B | 5.12B | 5.08B | 5.08B | 5.09B |
| Total liabilities | 22,878,000,000.00 | 21,279,000,000.00 | 23,079,000,000.00 | 22,572,000,000.00 | 22,227,000,000.00 | 22,333,000,000.00 |
| Total equity | 32.29B | 33.41B | 34.04B | 35.10B | 35.41B | 35.85B |
| Retained earnings | 1.45B | 2.70B | 3.43B | 4.97B | 5.72B | 6.58B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.83B | 2.87B | 4.88B | 4.28B | 3.22B | 2.76B | 6.36B | 10.33B |
| Depreciation & amortization | 1.22B | 1.96B | 2.30B | 2.32B | 2.19B | 2.11B | 2.58B | 2.52B |
| Free cash flow | 795.00M | 1.40B | 3.58B | 2.63B | 1.09B | 97.00M | 2.96B | 7.30B |
| Dividends paid | -301.00M | -889.00M | -834.00M | -1.76B | -1.75B | -1.42B | -1.15B | -1.11B |
| Stock buybacks / issuance | -98.00M | -479.00M | -521.00M | -525.00M | 0 | 0 | -1.25B | -2.30B |
| Ending cash balance | 3.49B | 2.35B | 5.65B | 5.09B | 2.94B | 3.10B | 3.65B | 7.68B |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Operating cash flow | 2.38B | 2.30B | 3.62B | 3.79B | 2.92B | 2.77B |
| Depreciation & amortization | 620.00M | 643.00M | 665.00M | 632.00M | 604.00M | 632.00M |
| Free cash flow | 1.71B | 1.57B | 2.81B | 3.14B | 2.21B | 1.91B |
| Dividends paid | -279.00M | -273.00M | -272.00M | -282.00M | -277.00M | -272.00M |
| Stock buybacks / issuance | -1.01B | -516.00M | -428.00M | -1.90B | -1.57B | -1.78B |
| Ending cash balance | 6.22B | 5.67B | 7.68B | 8.81B | 9.04B | 8.88B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 3.23 | 17.57 | 12.74 | 5.18 | -2.07 | -10.31 | 11.36 | 22.21 |
| ROA %i | 1.65 | 9.24 | 6.96 | 2.85 | -1.09 | -5.31 | 5.99 | 12.49 |
| ROIC %i | 3.07 | 13.89 | 10.49 | 4.65 | -1.18 | -7.58 | 9.05 | 18.11 |
| 5-year avg ROE %i | 0.70 | 3.22 | 5.36 | 7.53 | 7.33 | 4.62 | 3.38 | 5.27 |
| EBIT margin %i | 13.03 | 41.01 | 30.02 | 11.31 | 1.48 | -15.14 | 26.51 | 51.04 |
| FCF / sales %i | 10.96 | 14.40 | 31.14 | 21.49 | 9.14 | 0.82 | 15.85 | 32.20 |
| Current ratioi | 2.95 | 2.63 | 2.52 | 2.90 | 2.23 | 1.25 | 1.63 | 2.29 |
| Quick ratioi | 2.07 | 1.20 | 1.86 | 2.04 | 1.52 | 0.63 | 0.69 | 1.75 |
| Debt / assetsi | 20.57 | 17.28 | 16.20 | 15.54 | 15.93 | 17.00 | 15.92 | 9.78 |
| LT debt / equityi | 34.36 | 31.66 | 26.27 | 27.74 | 31.19 | 25.49 | 26.53 | 16.15 |
| Interest coveragei | 4.57 | 13.27 | 11.20 | 5.04 | 0.78 | -7.36 | 13.21 | 50.53 |
| Revenue CAGR (3Y) %i | 6.03 | 13.40 | 15.93 | 19.00 | 6.95 | 0.91 | 15.19 | 23.91 |
| Net income CAGR (3Y) %i | 15.73 | -- | -- | 50.65 | -- | -- | 42.13 | -- |
| FCF CAGR (3Y) %i | -1.58 | -5.32 | 41.71 | 48.93 | -8.10 | -69.96 | 4.08 | 88.54 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| ROE %i | 20.42 | 22.84 | 22.21 | 25.56 | 25.53 | 26.82 |
| ROA %i | 11.33 | 12.97 | 12.49 | 14.94 | 15.24 | 16.37 |
| ROIC %i | 16.30 | 18.68 | 18.11 | 21.12 | 21.15 | 22.79 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 43.84 | 48.55 | 51.04 | 54.65 | 52.37 | 53.28 |
| FCF / sales %i | 25.86 | 28.47 | 32.20 | 37.00 | 37.77 | 37.86 |
| Current ratioi | 2.23 | 2.04 | 2.29 | 2.44 | 2.55 | 2.45 |
| Quick ratioi | 1.56 | 1.38 | 1.75 | 1.89 | 1.95 | 1.86 |
| Debt / assetsi | 13.79 | 10.33 | 9.78 | 9.59 | 9.71 | 9.60 |
| LT debt / equityi | 23.34 | 16.66 | 16.15 | 15.51 | 15.51 | 15.28 |
| Interest coveragei | 27.94 | 36.12 | 50.53 | 72.19 | 84.87 | 102.72 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Quote time 2026-11-20 20:02:19 · For reference only, not investment advice and not tailored to your situation.
Newmont discussion 0 comments